DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Documents Phosphodiesterase Inhibitors in Therapeutics

PHOSPHODIESTERASE INHIBITORS IN THERAPEUTICS ROAD MAP ´ Introduction Classification and distribution of enzymes Phosphodiesterase inhibitors in therapeutics Recent advances…

Documents Case Study

I. Introduction Pneumonia is an illness of the lungs and respiratory system in which the alveoli (microscopic air-filled sacs of the lung responsible for absorbing oxygen…

Health & Medicine Tivicay®

1. TIVICAY® (TIV-eh-kay) (Dolutegravir) 2. Date of Approval: August 12, 2013 Approved by :U.S. Food and Drug Administration (FDA) Company: ViiV Healthcare Generic Name :…

Documents Durban slides

1. Reid RubsamenHIV/TB CLINICAL RESEARCHDURBAN 2. PheZulu Safari ParkZulu Hut Zulu Tribe Performers 3. Caprisa Research and Treatment ClinicParallel work on TB and HIV 4.…

Documents Clopidogrel resistance

1. “Clopidigrel resistance” andmanagement strategies 2. Overview• Physiology of platelet function and clopidogrelpharmacology• Definition of clopidogrel resistance•…

Documents Presents The Canine Thyroid Epidemic with Dr Jean Dodds, D.V.M. In support of Hemopet.

Slide 1presents The Canine Thyroid Epidemic with Dr Jean Dodds, D.V.M. In support of Hemopet Slide 2 Since 1994 Slide 3 Dr Jean Dodds, D.V.M. WELCOME Slide 4 4 Slide 5 www.hemopet.org…

Documents Depression in Women: From PMS to Post-partum Blues Kimberley Guida, MD Pullman Family Medicine.

Slide 1Depression in Women: From PMS to Post-partum Blues Kimberley Guida, MD Pullman Family Medicine Slide 2 Case Presentation Julie is a 25 year old female who just delivered…

Documents Initial Treatment of Tuberculosis Your name Institution/organization Meeting Date International...

Slide 1Initial Treatment of Tuberculosis Your name Institution/organization Meeting Date International Standards 7, 8, 10, 13, 17, 21 Slide 2 ISTC TB Training Modules 2009…

Documents A phase I study of CHR-2797, an orally active aminopeptidase inhibitor, in elderly and/or treatment....

Slide 1A phase I study of CHR-2797, an orally active aminopeptidase inhibitor, in elderly and/or treatment refractory patients with acute myeloid leukemia or multiple myeloma…